Patient-Concerned Other Dyads' 12-Step Involvement and Patients' Substance Use: A Latent Class Growth Model Analysis.
Journal
Journal of studies on alcohol and drugs
ISSN: 1938-4114
Titre abrégé: J Stud Alcohol Drugs
Pays: United States
ID NLM: 101295847
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
pmc-release:
01
09
2024
medline:
26
10
2023
pubmed:
23
5
2023
entrez:
23
5
2023
Statut:
ppublish
Résumé
This study aimed to inform clinical practice by identifying subgroups of patient-concerned other (CO) dyads. Patients with alcohol use disorders (AUDs) were characterized on Alcoholics Anonymous (AA) involvement and substance use together with COs' Al-Anon involvement. Predictors and recovery maintenance outcomes of subgroup membership were examined. Participants were 279 patient-CO dyads. Patients were in residential treatment for AUD. Parallel latent class growth model analysis characterized 12-step involvement and substance use at treatment entry and 3-, 6-, and 12-month follow-ups. Three classes were as follows: 38% Low AA/Low Al-Anon (patients' low AA and COs' low Al-Anon involvement, and patients' high-to-moderate substance use), 10% High AA/High Al-Anon (patients' high AA and COs' high Al-Anon involvement, and patients' moderate-to-low substance use), and 52% High AA/Low Al-Anon (patients' high AA and COs' low Al-Anon involvement, and patients' moderate-to-low substance use). At follow-up, the Low AA/Low Al-Anon classes' patients were less likely to have spirituality as recovery support, confidence about staying abstinent, and satisfaction with recovery progress. The High AA classes' COs had less concern about patients' drinking and scored higher on positive aspects of relationships with patients. Clinicians should encourage patients' and COs' 12-step group involvement (12-step practices' engagement). Among patients treated for AUD, AA involvement was related to better outcomes, and to COs' lessened concern about the patients' drinking. COs' Al-Anon involvement was associated with having a more positive view of their relationship with the patient. That more than one third of dyads had low 12-step group involvement suggests that treatment programs may need to facilitate involvement in non-12-step mutual-help groups.
Identifiants
pubmed: 37219032
doi: 10.15288/jsad.22-00378
pmc: PMC10600972
doi:
Banques de données
ClinicalTrials.gov
['NCT04018560']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
762-771Subventions
Organisme : NIDA NIH HHS
ID : K01 DA053391
Pays : United States
Organisme : NIDA NIH HHS
ID : L30 DA056944
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA024136
Pays : United States
Organisme : HSRD VA
ID : RCS 00-001
Pays : United States
Références
Psychol Addict Behav. 2017 Feb;31(1):54-60
pubmed: 28080094
J Subst Abuse Treat. 2018 May;88:18-26
pubmed: 29606223
J Relig Health. 2019 Oct;58(5):1713-1750
pubmed: 31359242
Issues Ment Health Nurs. 2021 May;42(5):430-436
pubmed: 33886421
Psychol Addict Behav. 2013 Dec;27(4):1132-40
pubmed: 23586453
Am J Addict. 2015 Oct;24(7):578-81
pubmed: 26300219
Drug Alcohol Depend. 2021 Feb 1;219:108439
pubmed: 33333362
Qual Health Res. 2012 Jan;22(1):17-30
pubmed: 21490294
J Consult Clin Psychol. 2020 Jun;88(6):526-540
pubmed: 32162930
Br J Psychiatry. 2007 Mar;190:248-54
pubmed: 17329746
J Subst Abuse Treat. 2013 Feb;44(2):216-23
pubmed: 22763197
Alcohol Clin Exp Res. 2014 Nov;38(11):2688-94
pubmed: 25421504
Drug Alcohol Depend. 2021 Nov 1;228:108983
pubmed: 34507007
J Subst Abuse Treat. 2019 Apr;99:139-148
pubmed: 30797386
Psychol Addict Behav. 2017 Nov;31(7):818-827
pubmed: 28836796
Psychiatr Serv. 2017 Dec 1;68(12):1207-1209
pubmed: 28945178
Subst Abus. 2022 Dec;43(1):1268-1276
pubmed: 35849747
J Consult Clin Psychol. 2016 Jun;84(6):497-510
pubmed: 26963601
Addict Sci Clin Pract. 2015 Mar 14;10:9
pubmed: 25928427
Drug Alcohol Depend. 2019 Aug 1;201:227-235
pubmed: 31254749
Addict Behav. 2022 May;128:107232
pubmed: 35042001
J Addict Med. 2019 Jul/Aug;13(4):300-305
pubmed: 30633045
Alcohol Clin Exp Res. 2019 Sep;43(9):1986-1993
pubmed: 31335974
Am J Drug Alcohol Abuse. 2020 Nov 1;46(6):731-738
pubmed: 32870030
J Subst Abuse Treat. 2013 Mar;44(3):256-63
pubmed: 22898042
Addict Behav. 2014 Jun;39(6):1042-9
pubmed: 24630826
Psychiatr Serv. 2021 Dec 1;72(12):1455-1459
pubmed: 34074145
J Subst Abuse Treat. 2020 Jun;113:108003
pubmed: 32359669
Addict Behav. 2019 Jun;93:204-211
pubmed: 30738929
Alcohol Res. 2021 May 06;41(1):06
pubmed: 33981521
J Stud Alcohol Drugs. 2021 May;82(3):395-400
pubmed: 34100708
Addiction. 2022 Mar;117(3):590-599
pubmed: 34427006
Psychol Addict Behav. 2014 Sep;28(3):928-34
pubmed: 24274437
Drug Alcohol Depend. 2021 Oct 1;227:108943
pubmed: 34390964
Alcohol Alcohol. 2020 Oct 20;55(6):641-651
pubmed: 32628263